Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
PRE 14A - TruGolf Holdings, Inc. (0001857086) (Filer)
10-Q - TruGolf Holdings, Inc. (0001857086) (Filer)
S-1 - TruGolf Holdings, Inc. (0001857086) (Filer)
8-K - TruGolf Holdings, Inc. (0001857086) (Filer)
8-K - TruGolf Holdings, Inc. (0001857086) (Filer)
8-K - Deep Medicine Acquisition Corp. (0001857086) (Filer)
25-NSE - Deep Medicine Acquisition Corp. (0001857086) (Subject)
425 - Deep Medicine Acquisition Corp. (0001857086) (Subject)
8-K - Deep Medicine Acquisition Corp. (0001857086) (Filer)
425 - Deep Medicine Acquisition Corp. (0001857086) (Subject)
Fastest customizable press release news feed in the world
SALT LAKE CITY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TruGolf, Inc. (NASDAQ:TRUG) ("TruGolf"), among the leading sellers and distributors of golf simulator software and hardware with headquarters in Salt Lake City, Utah, and Deep Medicine Acquisition Corp. ("DMAQ"), a publicly traded special purpose acquisition company, today announced that their previously announced business combination (the "Business Combination") has closed, resulting in TruGolf becoming a publicly-traded company. In connection with the consummation of the business combination, the combined public company was renamed "TruGolf Holdings, Inc." The Business Combination and all other proposals presented were approved at an ext
SALT LAKE CITY, Jan. 12, 2024 (GLOBE NEWSWIRE) -- TruGolf, Inc. ("TruGolf"), a leading golf simulator manufacturer and distributor with headquarters in Salt Lake City, Utah, and Deep Medicine Acquisition Corp. ("DMAQ"), a publicly traded special purpose acquisition company, today announced that on December 27, 2023, that the U.S. Securities and Exchange Commission ("SEC") has declared effective the registration statement on Form S-4 (as amended, the "Registration Statement") filed with the SEC related to the previously announced business combination among TruGolf and DMAQ (the "Business Combination"). DMAQ has also filed with the SEC the definitive proxy statement for its special meeting o
SALT LAKE CITY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- – Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) ("DMAQ" ), a publicly traded special purpose acquisition company, and TruGolf, Inc. ("TruGolf"), a leading golf simulator manufacturer and distributor with headquarters in Salt Lake City, Utah, today announced that on July 31, 2023, DMAQ filed a registration statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed business combination (the "Business Combination") between DMAQ and TruGolf, which was first announced on March 31, 2023. The Registration Statement contains a preliminary proxy statement / prospectus in co
TruGolf, Inc. ("TruGolf") will become a public company to further advance its software business and increase manufacturing and sales of its golf simulator technology in the United States and internationally. The business combination with Deep Medicine Acquisition Corp. values TruGolf's at an implied enterprise value of $125 million, including certain payments contingent on future milestones. ●The public listing enables TruGolf to accelerate its software development, golf simulator manufacturing and sales, as well as finalize new-generation hardware and software technology that aim to revolutionize the virtual golf experience. ●The proceeds from the transaction will enhance TruGolf's pro
New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) (the "Company") announced today that it has received approval from the Nasdaq Stock Market ("Nasdaq") to transfer the listing of its securities from the Nasdaq Global Market to the Nasdaq Capital Market. The Company's Class A common stock and rights will continue to trade under the symbol "DMAQ" and "DMAQR," respectively and trading of its Class A common stock and rights will be unaffected by this transfer. This transfer will be effective as of the opening of business on February 17, 2023. As previously disclosed, the Company received a letter from Nasdaq on January 22, 2023 indicating that the C
New York, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) (the "Company") announced today the appointment of Mr. John Chiang as a member to its board of directors, effective October 15, 2022. Mr. Chiang has been serving as a member of the board of directors of Apollo Medical Holdings, Inc. since January 2019 and on the corporate advisory boards of Pasadena Private Lending, LLC since February 2019, Adept Urban since January 2021, and Calyx Peak Companies since February 2019. From January 2015 to January 2019, Mr. Chiang served as the California State Treasurer, where he oversaw financial transactions, investments and the sale of bonds. Prior to that, Mr.
New York, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) (the "Company"), announced today that an aggregate of $1,265,000 has been deposited into the Company's trust account for its public shareholders, representing $0.10 per public share, which enables the Company to extend the period of time it has to consummate its initial business combination by three months from October 29, 2022 to January 29, 2023 (the "Extension"). The Extension is the first of up to two three-month extensions permitted under the Company's governing documents. About Deep Medicine Acquisition Corp. DMAQ is a special purpose acquisition company formed for the purpose of enter
Business combination agreement with Deep Medicine Acquisition Corp. values Chijet's operating companies at $2.55 billion (based on 100% ownership) ●Achieving the public listing milestone would enable Chijet to accelerate its electric vehicle development, manufacturing and sales, while expanding sales and production of conventional gas-fueled hybrid vehicles, leveraging its more than 300 dealerships in China and Southeast Asia and current annual production capacity of 240,000 vehicles at its existing 13.85 million-square-foot production base in Jilin City, China. ●Expected net proceeds of up to approximately $127.8 million upon the closing (assuming no redemptions by DMAQ public shareholder
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - TruGolf Holdings, Inc. (0001857086) (Issuer)
3 - TruGolf Holdings, Inc. (0001857086) (Issuer)
3 - TruGolf Holdings, Inc. (0001857086) (Issuer)
3 - TruGolf Holdings, Inc. (0001857086) (Issuer)
3 - TruGolf Holdings, Inc. (0001857086) (Issuer)
4 - Deep Medicine Acquisition Corp. (0001857086) (Issuer)
3 - Deep Medicine Acquisition Corp. (0001857086) (Issuer)
4 - Deep Medicine Acquisition Corp. (0001857086) (Issuer)
4 - Deep Medicine Acquisition Corp. (0001857086) (Issuer)
4 - Deep Medicine Acquisition Corp. (0001857086) (Issuer)
This live feed shows all institutional transactions in real time.
SC 13G/A - TruGolf Holdings, Inc. (0001857086) (Subject)
SC 13G/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13D/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G/A - Deep Medicine Acquisition Corp. (0001857086) (Subject)
SC 13G - Deep Medicine Acquisition Corp. (0001857086) (Subject)